Aquestive Therapeutics (AQST) News Today → $25,000 into $109,616 in two months? (From WealthPress) (Ad) Free AQST Stock Alerts $4.32 -0.06 (-1.37%) (As of 11:33 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineComing FDA Approvals Could Send These 3 Drug Stocks Soaringinvestorplace.com - April 17 at 8:00 AMAquestive Therapeutics to Present Crossover Study Data for Libervant™ (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurologyglobenewswire.com - April 12 at 4:01 PMPiper starts Aquestive at overweight, cites allergy reaction treatmentmsn.com - April 11 at 5:43 PMAquestive Therapeutics a new overweight at Piper on oral film productsmsn.com - April 11 at 5:43 PMAquestive Therapeutics (NASDAQ:AQST) Coverage Initiated by Analysts at Piper Sandlermarketbeat.com - April 11 at 7:35 AMAquestive Therapeutics (NASDAQ:AQST) Receives "Buy" Rating from HC Wainwrightmarketbeat.com - April 5 at 8:20 AMRaymond James Begins Coverage on Aquestive Therapeutics (NASDAQ:AQST)marketbeat.com - March 28 at 8:28 AMAquestive Therapeutics Announces Closing of Underwritten Public Offering of Common Stockglobenewswire.com - March 25 at 8:00 AMLegato Capital Management LLC Makes New $688,000 Investment in Aquestive Therapeutics, Inc. (NASDAQ:AQST)marketbeat.com - March 25 at 6:10 AMAquestive Therapeutics slumps 13%, prices $75M offeringmsn.com - March 20 at 7:31 PMWhy Is Aquestive Therapeutics (AQST) Stock Down 14% Today?investorplace.com - March 20 at 8:46 AMAquestive Therapeutics, Inc. (NASDAQ:AQST) Insider Alexander Mark Schobel Sells 50,000 Sharesinsidertrades.com - March 20 at 6:38 AMAquestive Therapeutics Announces Pricing of $75 Million Underwritten Public Offering of Common Stockglobenewswire.com - March 19 at 9:49 PMInsider Sell: Chief Innovation/Tech Officer Alexander Schobel Sells 50,000 Shares of Aquestive ...finance.yahoo.com - March 19 at 5:48 PMAquestive Therapeutics, Inc. (NASDAQ:AQST) Insider Sells $300,000.00 in Stockmarketbeat.com - March 19 at 4:59 PMAquestive Therapeutics Announces Proposed Public Offering of Common Stockglobenewswire.com - March 19 at 4:01 PMHC Wainwright Increases Aquestive Therapeutics (NASDAQ:AQST) Price Target to $9.00marketbeat.com - March 18 at 3:11 PMAquestive Therapeutics, Inc. (NASDAQ:AQST) Sees Large Decline in Short Interestmarketbeat.com - March 18 at 12:48 AM5 Growth Stocks Under $50 for March 2024msn.com - March 15 at 1:54 PMAnalysts Conflicted on These Healthcare Names: Allogene Therapeutics (ALLO), Aquestive Therapeutics (AQST) and Allakos (ALLK)markets.businessinsider.com - March 15 at 8:53 AMAquestive Therapeutics Announces Pivotal Study for Anaphylm™ (epinephrine) Sublingual Film Successfully Meets Primary and Secondary Endpoints and Provides Clinical Development Update Following FDA Meetingglobenewswire.com - March 14 at 5:23 PMAquestive Therapeutics, Inc. (NASDAQ:AQST) Insider Alexander Mark Schobel Sells 25,000 Sharesinsidertrades.com - March 13 at 7:00 AMInsider Sell: Chief Innovation/Tech Officer Alexander Schobel Sells 25,000 Shares of Aquestive ...finance.yahoo.com - March 12 at 6:07 PMAquestive Therapeutics, Inc. (NASDAQ:AQST) Insider Sells $129,750.00 in Stockmarketbeat.com - March 12 at 4:39 PMAquestive Therapeutics price target raised by $1 at H.C. Wainwright, here's whyrealmoney.thestreet.com - March 11 at 12:57 PMAnalysts Issue Forecasts for Aquestive Therapeutics, Inc.'s Q1 2024 Earnings (NASDAQ:AQST)marketbeat.com - March 11 at 2:18 AMAquestive Therapeutics, Inc. (AQST) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 8 at 10:53 AMAquestive Therapeutics, Inc. (NASDAQ:AQST) Expected to Post Q2 2024 Earnings of ($0.08) Per Sharemarketbeat.com - March 8 at 6:50 AMAquestive Therapeutics Inc Reports Full Year 2023 Financial Resultsfinance.yahoo.com - March 7 at 6:37 PMAquestive Therapeutics price target raised by $5 at Lake Street, here's whyrealmoney.thestreet.com - March 7 at 1:37 PMAquestive Therapeutics, Inc. (NASDAQ:AQST) Q4 2023 Earnings Call Transcriptinsidermonkey.com - March 7 at 1:01 PMAquestive Therapeutics Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lagsfinance.yahoo.com - March 7 at 8:36 AMQ4 2023 Aquestive Therapeutics Inc Earnings Callfinance.yahoo.com - March 7 at 2:03 AMAquestive Therapeutics, Inc.: Aquestive Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updatefinanznachrichten.de - March 6 at 9:02 PMReiterating Outperform Rating on Aquestive: Buy Recommendation Amid Promising Anaphylm Developments and Strategic Market Positioningmarkets.businessinsider.com - March 6 at 9:02 PMBuy Rating Affirmed for Aquestive Therapeutics Amid Strong Pipeline and Market Potentialmarkets.businessinsider.com - March 6 at 4:02 PMAQST Stock Earnings: Aquestive Therapeutics Misses EPS, Beats Revenue for Q4 2023investorplace.com - March 5 at 11:33 PMAquestive Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updateglobenewswire.com - March 5 at 5:05 PMAQST Mar 2024 7.500 callfinance.yahoo.com - March 4 at 6:28 PMAquestive Therapeutics Q4 Earnings Previewmsn.com - March 4 at 6:28 PMAquestive Therapeutics is about to announce its earnings — here's what to expectmarkets.businessinsider.com - March 4 at 1:04 PMAquestive Therapeutics, Inc. (NASDAQ:AQST) Sees Large Increase in Short Interestmarketbeat.com - March 4 at 7:41 AMArmistice Capital LLC Raises Stock Holdings in Aquestive Therapeutics, Inc. (NASDAQ:AQST)marketbeat.com - March 3 at 10:50 AMAcadian Asset Management LLC Has $841,000 Holdings in Aquestive Therapeutics, Inc. (NASDAQ:AQST)marketbeat.com - February 29 at 5:46 AMAquestive (AQST) to Report Q4 Earnings: Here's What to Expectfinance.yahoo.com - February 21 at 2:39 PMAquestive Therapeutics to Report Fourth Quarter 2023 Financial Results and Recent Business Highlights on March 5 and Host Conference Call on March 6 at 8:00 a.m. ETfinance.yahoo.com - February 21 at 9:39 AMAquestive Therapeutics to Report Fourth Quarter 2023 Financial Results and Recent Business Highlights on March 5 and Host Conference Call on March 6 at 8:00 a.m. ETglobenewswire.com - February 21 at 8:00 AMAquestive Therapeutics (AQST) Registers a Bigger Fall Than the Market: Important Facts to Notefinance.yahoo.com - February 20 at 7:45 PMAquestive Therapeutics Inc (AQST)investing.com - February 16 at 10:24 AMBuy Rating Affirmed for Aquestive Therapeutics Amidst PharmFilm Progress and Anticipated Clinical Milestonesmarkets.businessinsider.com - February 15 at 7:52 PM Get Aquestive Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AQST and its competitors with MarketBeat's FREE daily newsletter. Email Address Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached. Secure Your Spot Now AQST Media Mentions By Week AQST Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AQST News Sentiment▼1.000.46▲Average Medical News Sentiment AQST News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AQST Articles This Week▼12▲AQST Articles Average Week Get Aquestive Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AQST and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: KMDA News RAPT News XOMA News VSTM News NKTR News XBIT News PYXS News ERAS News AKBA News PRLD News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AQST) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishingtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders[Shocking] Elon Musk’s Plan To End BanksCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aquestive Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
